FDA Import Refusal H77-0229191-2/13/1 — Harbin Jixianglong Biotech Co., Ltd.
The FDA refused shipment H77-0229191-2/13/1 from Harbin Jixianglong Biotech Co., Ltd. (China) on Aug 6, 2025. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charge: 2280 This firm has 1 other import refusal on record.
Refusal Details
- Date
- Aug 6, 2025
- Country
- China
- Product Category
- Drugs and Biologics
- Product Code
- 61PCT72 SEMAGLUTIDE (ANTI-DIABETIC)
- Charges
- 2280